Our state-of-the-art analytical testing labs support drug substance (API) and drug product (finished product) analytics across all phases of clinical development and into commercial release.
Analytical testing is undertaken to ensure drugs are safe, effective and of the highest quality. Pharmaceutical analytical services cover a broad spectrum of activities and techniques including stability testing, bioanalytical testing, method development and validation, raw material testing, QC release testing and physical characterisation of materials.
We employ over 170 highly skilled analysts working in GMP / GLP environments across the UK, Europe, and the US with significant experience in the analysis of both small and large molecules. Our in-depth technical expertise combined with a wide range of advanced analytical instrumentation delivers fast and reliable results.
All our analytical testing laboratories are fully certified by the appropriate authorities (FDA, MHRA, INAB, HPRA).
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides,
biologics, conjugates, highly potent and controlled substances. Our vast pool of scientific knowledge can help to overcome the analytical challenges that
typically arise during drug development.
Dr. Solomon Befekadu Abebe
Crystallisation and Downstream Processes Development Team Leader
My skills include different approaches of developing crystallisation and downstream processes for the manufacture of solid API as well as the ability to build mathematical models using various statistical data analysis techniques such as chemometrics and process simulating techniques such as Dynochem.
My educational background is a combination in a variety of engineering disciplines. I have received BEng in Mechanical Engineering, MSc in Process Engineering and a PhD in Particle Science and Engineering degrees from Middlesex University, Cranfield University and University of Leeds, UK respectively.
I have worked in various projects in prestigious pharmaceutical companies such as Pfizer as Material Scientist (UK), Novartis as a Senior Scientist (Switzerland), GlaxoSmithKline (UK) as a Process Analytical Technology (PAT) engineer and currently at Almac Group (UK) as team leader.
I have several accomplishments, but nothing beats involvement in a blockbuster medicine Seebri and Ultibro Breezhalers for the treatment of chronic obstructive pulmonary disease (COPD) for which I was a core member of a team who developed the API process.
“Given their expertise in drug substance and drug product development, Almac’s Physical Sciences Team were especially well positioned to identify physical forms that may give rise to valuable sources of intellectual property.”Biotechnology company
“Almac’s analytical team continually demonstrate that we can rely on their services and timelines as promised.”Large Pharmaceutical company
Webinar: Crystallisation and Downstream Processes
Thursday 21st Oct 2pm GMT